FDA Drug Application (022103) for SANCTURA XR by ALLERGAN

Back to FDA Applications sponsored by ALLERGAN

Application Number022103
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage60MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSANCTURA XR
Active IngredientTROSPIUM CHLORIDE

Active IngredientCount
List of drugs with Active Ingredient TROSPIUM CHLORIDE3


Back to FDA Applications sponsored by ALLERGAN